CSIMarket
 


Fibrogen Inc   (FGEN)
Other Ticker:  
 

Cumulative Fibrogen Inc 's Quick Ratio for Trailing Twelve Months Period

FGEN's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

FGEN Quick Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Growth -16.9 % -19.25 % -0.25 % 21.32 % 20.39 %
Y / Y Cash & cash equivalent Growth -38.48 % -23.38 % -16.85 % 4.15 % -16.01 %
Quick Ratio for Trailing Twelve Months Period 1.46 1.56 1.59 1.66 1.73
Total Ranking # 1167 # 1221 # 1375 # 1521 # 1519
Seq. Current Liabilities Growth 7.91 % -23.82 % -6.88 % 8.56 % 4.85 %
Seq. Cash & cash equivalent Growth -25.13 % -5.68 % -15.65 % 3.3 % -6.76 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Despite year on year decrease in Fibrogen Inc 's average Current Liabilities to $209 millions, Quick Ratio for Trailing Twelve Months Period to 1.46 below company average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 370 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Fibrogen Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about FGEN
Quick Ratio FGEN in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 371
Sector # 672
S&P 500 # 1277


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
8.89 4.95 1.46
(Jun 30 2018)   (Sep 30 2023)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Catalyst Pharmaceuticals Inc   4.02 
Neubase Therapeutics inc   4.02 
Bridgebio Pharma Inc   4.00 
Sarepta Therapeutics Inc   3.98 
Imunon Inc   3.97 
Benitec Biopharma Inc   3.96 
Regulus Therapeutics Inc   3.95 
Mirum Pharmaceuticals Inc   3.91 
Immunogen inc   3.88 
Arvinas Inc   3.88 
Kiniksa Pharmaceuticals Ltd   3.86 
Proqr Therapeutics N v   3.86 
Alpine Immune Sciences Inc   3.81 
Travere Therapeutics Inc   3.80 
Puretech Health Plc  3.80 
Acurx Pharmaceuticals inc   3.79 
Affimed N v   3.78 
Theriva Biologics inc   3.73 
Y mabs Therapeutics inc   3.71 
Genelux Corporation  3.71 
Monopar Therapeutics Inc   3.70 
Karyopharm Therapeutics Inc   3.69 
Liminal Biosciences Inc   3.68 
Immunome Inc  3.65 
Mustang Bio inc   3.64 
Gt Biopharma Inc   3.62 
Apellis Pharmaceuticals Inc   3.62 
Siga Technologies Inc  3.61 
Alterity Therapeutics Limited  3.60 
Abivax Sa  3.60 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com